論文出處：J Dermatol Sci. 2018 Nov;92(2):188-196. doi: 10.1016/j.jdermsci.2018.09.002. Epub 2018 Sep 7.
論文名稱：The atopic dermatitis-like lesion and the associated MRSA infection and barrier dysfunction can be alleviated by 2,4-dimethoxy-6-methylbenzene-1,3-diol from Antrodia camphorata.
作 者：Yang SC, Huang TH, Chiu CH, Chou WL, Alalaiwe A, Yeh YC, Su KW, Fang JY.
出 版 年：2018
2,4-Dimethoxy-6-methylbenzene-1,3-diol (DMD), is a benzenoid isolated from Antrodia camphorata, exhibited a comparative minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) against methicillin-resistant S. aureus (MRSA) with nalidixic acid, a conventional antibiotic. Demonstrated an advanced concept of Atopic dermatitis (AD, an inflammatory skin disease) treatment by combined barrier repair and bacterial eradication with a sole agent for ameliorating the overall complications.